Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $1.57B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
ANI Pharmaceuticals USD 1.46B 206M Nov/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Canopy Growth CAD 88.38M 494.19M Nov/2026
Cara Therapeutics USD 30M 336M Mar/2026
Corcept Therapeutics USD 7.63B 4.83B Nov/2026
Eisai JPY 1.41T 5.37B Nov/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 1.7B 696M Nov/2026
Perrigo USD 2.17B 31M Nov/2026
Pfizer USD 165.12B 1.71B Nov/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
United Therapeutics USD 28.64B 5.4B Nov/2026
Xeris Pharmaceuticals USD 1.44B 70M Nov/2026